Investors
- Stock Information
- News Releases
- Corporate Governance
- SEC Filings
- Annual Reports
- Financial Reports
- Event Calendar
- Presentations
- Non-GAAP Measures
- FAQ
- Information Request
- Analyst Coverage
For Pharmaceuticals
spin-off information,
click here.
| Primary IR Contact |
| Coleman Lannum, CFA Vice President – Investor Relations Phone: 508-452-4343 E-mail: cole.lannum@covidien.com |
| Todd Carpenter Senior Director – Investor Relations Phone: 508-452-4363 E-mail: todd.carpenter@covidien.com |